ストックスクリーナーアプリを入手
1.10
0.92%
0.01
プレマーケット:
1.15
0.05
+4.55%
前日終値:
$1.09
開ける：
$1.15
24時間の取引高:
56,504
Relative Volume:
0.43
時価総額：
$6.15M
収益：
-
当期純損益:
$-3.12M
株価収益率:
-0.2285
EPS:
-4.8149
ネットキャッシュフロー:
$-2.69M
1週間 パフォーマンス:
+1.85%
1か月 パフォーマンス:
+29.47%
6か月 パフォーマンス:
-63.09%
1年 パフォーマンス:
-43.01%
1日の値動き範囲:
$1.07
$1.1568
1週間の範囲:
$1.02
$1.2284
52週間の値動き範囲:
$0.6578
$17.75
180 Life Sciences Corp Stock (ATNF) Company Profile
ATNF を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ATNF
180 Life Sciences Corp
|
1.10 | 6.15M | 0 | -3.12M | -2.69M | -4.8149 |
|
VRTX
Vertex Pharmaceuticals Inc
|
439.37 | 128.45B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.63 | 65.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
560.90 | 40.09B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.19 | 35.67B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
233.25 | 27.44B | 3.81B | -644.79M | -669.77M | -6.24 |
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-09-15 | 開始されました | Maxim Group | Buy |
180 Life Sciences Corp (ATNF) 最新ニュース
180 Life Sciences’ (ATNF) Sell (E+) Rating Reiterated at Weiss Ratings - Defense World
180 Life Sciences Announces That the University of Oxford Has Been Awarded a Grant From the National Institute for Health and Care Research in the U.K. to Conduct a Clinical Trial in Post Operative Delirium/Cognitive Deficit in a Jointly Funded Program - Barchart.com
ATNF’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
180 Life Sciences Gets Notice of Allowance for Method to Prevent POCD - marketscreener.com
MAGIC Nashville Showcases Premier Southeastern Women's Fashion Trends and Innovations - Digital Journal
180 Life Sciences (ATNF) Secures Patent Approval for POCD Treatm - GuruFocus
180 Life Sciences nears patent for post-surgery cognitive aid By Investing.com - Investing.com India
180 Life Sciences nears patent for post-surgery cognitive aid - Investing.com
180 Life Sciences Corp. Announces Notice of Allowance for U.S. P - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
Patent Breakthrough: 180 Life Sciences Develops First Treatment to Prevent Post-Surgery Cognitive Decline in Elderly - Stock Titan
Budapest Draws in Summer Visitors for an Adventure Along the Danube - Digital Journal
180 Life Sciences (ATNF) Restructures Capital with Share Repurch - GuruFocus
180 Life Sciences to buy back shares, simplifies capital structure By Investing.com - Investing.com India
180 Life Sciences Settles Disputes with Elray Resources - TipRanks
180 Life Sciences Corp. Announces Share Repurchase | ATNF Stock News - GuruFocus
180 Life Sciences to buy back shares, simplifies capital structure - Investing.com Australia
180 Life Sciences Launches Massive 23% Share Reduction Plan: Key Details of $1M Strategic Buyback - Stock Titan
180 Life Sciences Corp. (NASDAQ:ATNF) Sees Large Increase in Short Interest - Defense World
Short Interest in Adlai Nortye Ltd. (NASDAQ:ANL) Decreases By 51.6% - Defense World
180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector - ACCESS Newswire
180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules - ACCESS Newswire
180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
Layoff Tracker: Tempest Axes 80% of Workforce - BioSpace
Alliancebernstein L.P. Has $1.12 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Geode Capital Management LLC Sells 247,336 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Arrowstreet Capital Limited Partnership Has $312,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
Elray Resources Announces Strategic Sale of Crypto iGaming Technology - ADVFN
Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews
Weiss Ratings Reiterates Sell (E+) Rating for 180 Life Sciences (NASDAQ:ATNF) - Defense World
180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - The AM Reporter
ATNF stock touches 52-week low at $0.74 amid market shifts - Investing.com India
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors - ACCESS Newswire
180 Life Sciences Corp. SEC 10-K Report - TradingView
ATNF stock touches 52-week low at $0.98 amid market shifts - Investing.com
180 Life Sciences Corp. (ATNF) reports earnings - qz.com
Short Interest in 180 Life Sciences Corp. (NASDAQ:ATNF) Increases By 67.2% - Defense World
180 Life Sciences (NASDAQ:ATNF) versus Immunic (NASDAQ:IMUX) Head to Head Comparison - Defense World
Motor Neuron Disease Clinical Pipeline | 180+ Companies Advancing Next-Generation Therapies - openPR
180 Life Sciences (NASDAQ:ATNF) Given Sell (E+) Rating at Weiss Ratings - Defense World
180 Degree Capital (NASDAQ:TURN) Given Sell (D-) Rating at Weiss Ratings - Defense World
Synergy CHC (SNYR) Projected to Post Earnings on Monday - Defense World
Zydus Lifesciences shares rally 3% after FDA approval for prostate cancer drug - The Economic Times
180 Life Sciences Corp. (NASDAQ:ATNF) Short Interest Up 29.3% in February - Defense World
Janone Inc. (NASDAQ:ALTS) Short Interest Up 40.9% in February - Defense World
180 Life Sciences Corp. (NASDAQ:ATNF) Sees Large Growth in Short Interest - Armenian Reporter
180 Life Sciences Corp (ATNF) 財務データ
収益
当期純利益
現金流量
EPS
4.10%
大文字化:
|
ボリューム (24 時間):